Kelly Sinéad, Collins Jonathan, Maguire Maureen, Gowing Catriona, Flanagan Michelle, Donnelly Maria, Murphy Philip G
Department of Clinical Microbiology, The Adelaide and Meath Hospital Incorporating the National Children's Hospital, Tallaght, Dublin 24, Ireland.
J Antimicrob Chemother. 2008 Apr;61(4):901-7. doi: 10.1093/jac/dkn043. Epub 2008 Feb 13.
To report an outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit (ITU).
An outbreak of colonization with linezolid-resistant S. epidermidis affecting 16 patients in an ITU was investigated using PFGE. Environmental and staff screening was carried out as part of the investigation. Usage of linezolid in the hospital and in the ITU was reviewed. Resistant strains were screened for the presence of the G2576T mutation using PCR-RFLP genotyping. The interventions made to control the outbreak were restriction of linezolid prescription and specific infection control measures, including isolation of colonized patients and increased environmental cleaning.
Linezolid-resistant S. epidermidis strains from the 16 colonized patients were genetically related. The same strain was also cultured from environmental samples in the ITU. An increase in linezolid usage in the hospital and in the ITU occurred in the 6 months prior to the emergence of the resistant strain. Infection control measures and restriction of linezolid prescription controlled the outbreak. All resistant isolates contained the G2576T mutation.
An outbreak of colonization with linezolid-resistant S. epidermidis occurred in the ITU in our institution. The resistant strain colonized the environment and probably spread from patient to patient. The outbreak was associated with an increase in the linezolid usage in the ITU and in the institution as a whole. Restriction of linezolid usage and infection control measures were introduced to control the outbreak. The emergence of linezolid resistance in S. epidermidis has implications for the use of linezolid as a therapeutic agent.
报告重症监护病房(ITU)中耐利奈唑胺表皮葡萄球菌定植的暴发情况。
采用脉冲场凝胶电泳(PFGE)对ITU中16例受耐利奈唑胺表皮葡萄球菌定植影响的患者暴发情况进行调查。作为调查的一部分,对环境和工作人员进行了筛查。回顾了医院和ITU中利奈唑胺的使用情况。使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)基因分型法筛查耐药菌株中是否存在G2576T突变。为控制暴发采取的干预措施包括限制利奈唑胺处方以及采取特定的感染控制措施,包括隔离定植患者和加强环境清洁。
16例定植患者的耐利奈唑胺表皮葡萄球菌菌株具有遗传相关性。在ITU的环境样本中也培养出了相同的菌株。在耐药菌株出现前的6个月里,医院和ITU中利奈唑胺的使用量有所增加。感染控制措施和利奈唑胺处方的限制控制了暴发。所有耐药分离株均含有G2576T突变。
在我们机构的ITU中发生了耐利奈唑胺表皮葡萄球菌定植的暴发。耐药菌株在环境中定植,并可能在患者之间传播。此次暴发与ITU以及整个机构中利奈唑胺使用量的增加有关。采取了限制利奈唑胺使用和感染控制措施来控制暴发。表皮葡萄球菌中利奈唑胺耐药性的出现对利奈唑胺作为治疗药物的使用产生了影响。